Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes in MRI and CT in Relation to Histopathological Results - a Prospective, Randomised Study

NCT06527027 is registered in ClinicalTrials.gov with Copernicus Memorial Hospital as lead sponsor.

NCT NCT06527027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes in MRI and CT in Relation to Histopathological Results - a Prospective, Randomised Study
Lead sponsor
Copernicus Memorial Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2023
Completion date
December 31, 2028
Enrollment
1,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastasis, lymph node neoplasm